{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"mitochondrial-short-chain-enoyl-coa-hydratase-1-deficiency","columns":[{"gene":"","key":"population-383e39958671132a21fd","label":"Mitochondrial short-chain enoyl-coa hydratase 1 deficiency","mondoId":"MONDO:0014563","onsetQualifier":null,"originColumnKey":"MONDO:0014563/OMIM:616277","originalViews":[{"key":"MONDO:0014563/OMIM:616277","label":"Mitochondrial short-chain enoyl-coa hydratase 1 deficiency","scopeLabel":"OMIM:616277","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["0e219cb6d0887cd72f25f51aed88f9ab90cb8bd951d60a9dfe866ea79f0acd62","10648ca28d3d1c5c6f8173207de7c50104f777b261ad0d43f64c5a5a54a76de0","20fe4a7b739ff5447758e669e5d5e80ba0c0f7a23aef3c0c874264fa1511e3fb","252b8b8a2b8d5b141c342e7cb0e2c56d94c27babac2dee10c4b3b1f1adee067a","34639e30231c3b90a8599e64cedebb5b9b85a37fb555f0fc42ef63facf5e5104","3b08798afef6b0e8c978e24990f77a949993dd5e8bc3f99cd85391740f3344ac","3cf0a0ad4a8710c17e86e704031885c58cec8cf99d3a7230e3cc9180b8ddb830","504201c27a67af1b4dab94d1a0cc88858bff13ae994acd24fb21b265e6f620dc","58bc32504b7aea33fd45b53b78f21ff7606f0ffba562cb50dde901f2f168e0a4","59e0a3ad3dc3ebfc532c1bc94a5ebf6441e0a6d8251c520fc189c59ead0f5d8e","661f8c2fb0b3b214a63806a8624c28558b731943727cb4535c85b4a9efbd32bd","6c2db7fd34f68f3dcf2e7bce27f748b1a23ab2d71bd404971cebe421b204b183","6e7a0b5a032b4bc69d03f870321c335f841ac3be980c33e1390670b7bc3343ec","7559ca367a8f08d9da469276f197fc63dba6be8efc893cfabdde637c396f38e9","92a28e19384ed910b9b9f06033dc64493774856a83a09ed39db01602da5c589b","96587f5b220c611368c34752316d29965f4fa6a8ac6a91ab2ff50907e9f4ffe3","ae7b602ca6b883ec50c494c60fa434a2a6cedf9a6248ff058a067d2915d6fb9d","c55edac742928ff47c4c5421a61556d9f05d73ec647f0014ab1528960eabb1d6","d0180bd0a73017b7b1bea5f462e76a59781edf7c69600b6569bffbb4170438bb","d3d4bee3a10c39fa444152f9aa4c00303d00913f5c194c191bb005c3af96c7c1","d5f75443c96058b7688cdfe8887616c5430a421f4c29cbc157292c940954f6bd","da28cd39e3996fc7507165fdfafbba3707141d73dad2eb60152a88ea5372832a","df81931150baed6b864fa6ebc419c5856d7d45cc44528e4778e1c0951df58c14","fc5ec1eecf4e61bbb0467857ca6ef10e390728e2c4275effca66e2b0d0554c16"],"recordQualifiers":{},"scopeLabel":"OMIM:616277","sourceIds":["OMIM:616277"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-383e39958671132a21fd"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0002104","HP:0007366","HP:0001662","HP:0012444","HP:0002928","HP:0001332","HP:0012707"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":18,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":24,"sourceGroups":{"omim":6,"published":18}},"features":[{"hpoId":"HP:0002104","label":"Apnea","primary":true},{"hpoId":"HP:0007366","label":"Atrophy/Degeneration affecting the brainstem","primary":true},{"hpoId":"HP:0001662","label":"Bradycardia","primary":true},{"hpoId":"HP:0012444","label":"Brain atrophy","primary":true},{"hpoId":"HP:0002928","label":"Decreased activity of the pyruvate dehydrogenase complex","primary":true},{"hpoId":"HP:0001332","label":"Dystonia","primary":true},{"hpoId":"HP:0012707","label":"Elevated brain lactate level by MRS","primary":true},{"hpoId":"HP:6000469","label":"Elevated urine 2,3-dihydroxy-2-methylbutanoic acid level","primary":false},{"hpoId":"HP:0011968","label":"Feeding difficulties","primary":false},{"hpoId":"HP:0001290","label":"Generalized hypotonia","primary":false},{"hpoId":"HP:0001263","label":"Global developmental delay","primary":false},{"hpoId":"HP:0000365","label":"Hearing impairment","primary":false},{"hpoId":"HP:0001639","label":"Hypertrophic cardiomyopathy","primary":false},{"hpoId":"HP:0001252","label":"Hypotonia","primary":false},{"hpoId":"HP:0002151","label":"Increased circulating lactate concentration","primary":false},{"hpoId":"HP:0002490","label":"Increased CSF lactate","primary":false},{"hpoId":"HP:0000639","label":"Nystagmus","primary":false},{"hpoId":"HP:0002033","label":"Poor suck","primary":false},{"hpoId":"HP:0002878","label":"Respiratory failure","primary":false},{"hpoId":"HP:0011344","label":"Severe global developmental delay","primary":false},{"hpoId":"HP:0001257","label":"Spasticity","primary":false},{"hpoId":"HP:0033725","label":"Thin corpus callosum","primary":false},{"hpoId":"HP:0001629","label":"Ventricular septal defect","primary":false},{"hpoId":"HP:0010544","label":"Vertical nystagmus","primary":false}],"ledeHtml":"Mitochondrial short-chain enoyl-CoA hydratase 1 deficiency (ECHS1D) represents a clinical spectrum in which several phenotypes have been described: The most common phenotype presents in the neonatal period with severe encephalopathy and lactic acidosis and later manifests Leigh-like signs and symptoms. Those with presentation in the neonatal period typically have severe hypotonia, encephalopathy, or neonatal seizures within the first few days of life. Signs and symptoms typically progress quickly and the affected individual ultimately succumbs to central apnea or arrhythmia. A second group of affected individuals present in infancy with developmental regression resulting in severe developmental delay. A third group of affected individuals have normal development with isolated paroxysmal dystonia that may be exacerbated by illness or exertion. Across all three groups, T2 hyperintensity in the basal ganglia is very common, and may affect any part of the basal ganglia.","mondoId":"MONDO:0014563","node":{"canonicalSlug":"mitochondrial-short-chain-enoyl-coa-hydratase-1-deficiency","comparisons":[{"documentSha256":"4b38549264ef989fb6b9f8ab08493e252243440d97a5a2a4608a7db3908f952b","key":"legacy-mitochondrial-short-chain-enoyl-coa-hydratase-1-deficiency","kind":"legacy","label":"mitochondrial short-chain Enoyl-Coa hydratase 1 deficiency","memberIds":["MONDO:0014563"],"mondoId":"MONDO:0014563","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/mitochondrial-short-chain-enoyl-coa-hydratase-1-deficiency.4b38549264ef989fb6b9f8ab08493e252243440d97a5a2a4608a7db3908f952b.json"}],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"summary","independentCorroborationEstablished":false,"matchMethod":"automatic-identity-and-attribution","name":"Mitochondrial short-chain Enoyl-Coa hydratase 1 deficiency","originalSourceId":"OMIM:616277","paragraphs":["Mitochondrial short-chain enoyl-CoA hydratase 1 deficiency (ECHS1D) represents a clinical spectrum in which several phenotypes have been described: The most common phenotype presents in the neonatal period with severe encephalopathy and lactic acidosis and later manifests Leigh-like signs and symptoms. Those with presentation in the neonatal period typically have severe hypotonia, encephalopathy, or neonatal seizures within the first few days of life. Signs and symptoms typically progress quickly and the affected individual ultimately succumbs to central apnea or arrhythmia. A second group of affected individuals present in infancy with developmental regression resulting in severe developmental delay. A third group of affected individuals have normal development with isolated paroxysmal dystonia that may be exacerbated by illness or exertion. Across all three groups, T2 hyperintensity in the basal ganglia is very common, and may affect any part of the basal ganglia."],"rawAttribution":"GARD:0013019","reviewed":null,"scope":"exact","source":"GARD","sourceRelease":"2026-10-21T17:00:16Z","upstream":"GARD:0013019","url":"https://rarediseases.info.nih.gov/diseases/13019"},"ownColumnKeys":["population-383e39958671132a21fd"],"publication":"published","relationships":[{"kind":"parent","label":"hereditary disease","mondoId":"MONDO:0003847","slug":null},{"kind":"parent","label":"mitochondrial disease","mondoId":"MONDO:0044970","slug":null}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[],"translation":"pending"},"records":[{"frequencyKind":"count","key":"0e219cb6d0887cd72f25f51aed88f9ab90cb8bd951d60a9dfe866ea79f0acd62","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:616277","disease_name":"Mitochondrial short-chain enoyl-coa hydratase 1 deficiency","evidence":"PCS","frequency_raw":"2/2","hpo_id":"HP:0002151","is_excluded":false,"label":"Increased circulating lactate concentration","onset_id":null,"reference":"PMID:25125611","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"10648ca28d3d1c5c6f8173207de7c50104f777b261ad0d43f64c5a5a54a76de0","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:616277","disease_name":"Mitochondrial short-chain enoyl-coa hydratase 1 deficiency","evidence":"PCS","frequency_raw":"2/2","hpo_id":"HP:0002928","is_excluded":false,"label":"Decreased activity of the pyruvate dehydrogenase complex","onset_id":null,"reference":"PMID:25125611","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"20fe4a7b739ff5447758e669e5d5e80ba0c0f7a23aef3c0c874264fa1511e3fb","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:616277","disease_name":"Mitochondrial short-chain enoyl-coa hydratase 1 deficiency","evidence":"PCS","frequency_raw":"1/2","hpo_id":"HP:0011344","is_excluded":false,"label":"Severe global developmental delay","onset_id":null,"reference":"PMID:25125611","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"252b8b8a2b8d5b141c342e7cb0e2c56d94c27babac2dee10c4b3b1f1adee067a","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:616277","disease_name":"Mitochondrial short-chain enoyl-coa hydratase 1 deficiency","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0001263","is_excluded":false,"label":"Global developmental delay","onset_id":null,"reference":"OMIM:616277","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"count","key":"34639e30231c3b90a8599e64cedebb5b9b85a37fb555f0fc42ef63facf5e5104","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"OMIM:616277","disease_name":"Mitochondrial short-chain enoyl-coa hydratase 1 deficiency","evidence":"PCS","frequency_raw":"1/2","hpo_id":"HP:0001662","is_excluded":false,"label":"Bradycardia","onset_id":null,"reference":"PMID:25125611","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"3b08798afef6b0e8c978e24990f77a949993dd5e8bc3f99cd85391740f3344ac","raw":{"aspect":"P","body_system":"ear","disease_id":"OMIM:616277","disease_name":"Mitochondrial short-chain enoyl-coa hydratase 1 deficiency","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0000365","is_excluded":false,"label":"Hearing impairment","onset_id":null,"reference":"OMIM:616277","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"count","key":"3cf0a0ad4a8710c17e86e704031885c58cec8cf99d3a7230e3cc9180b8ddb830","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:616277","disease_name":"Mitochondrial short-chain enoyl-coa hydratase 1 deficiency","evidence":"PCS","frequency_raw":"4/4","hpo_id":"HP:6000469","is_excluded":false,"label":"Elevated urine 2,3-dihydroxy-2-methylbutanoic acid level","onset_id":null,"reference":"PMID:29575569","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"504201c27a67af1b4dab94d1a0cc88858bff13ae994acd24fb21b265e6f620dc","raw":{"aspect":"P","body_system":"eye","disease_id":"OMIM:616277","disease_name":"Mitochondrial short-chain enoyl-coa hydratase 1 deficiency","evidence":"PCS","frequency_raw":"1/2","hpo_id":"HP:0010544","is_excluded":false,"label":"Vertical nystagmus","onset_id":null,"reference":"PMID:25125611","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"58bc32504b7aea33fd45b53b78f21ff7606f0ffba562cb50dde901f2f168e0a4","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:616277","disease_name":"Mitochondrial short-chain enoyl-coa hydratase 1 deficiency","evidence":"PCS","frequency_raw":"1/2","hpo_id":"HP:0033725","is_excluded":false,"label":"Thin corpus callosum","onset_id":null,"reference":"PMID:25125611","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"59e0a3ad3dc3ebfc532c1bc94a5ebf6441e0a6d8251c520fc189c59ead0f5d8e","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:616277","disease_name":"Mitochondrial short-chain enoyl-coa hydratase 1 deficiency","evidence":"PCS","frequency_raw":"1/2","hpo_id":"HP:0007366","is_excluded":false,"label":"Atrophy/Degeneration affecting the brainstem","onset_id":null,"reference":"PMID:25125611","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"661f8c2fb0b3b214a63806a8624c28558b731943727cb4535c85b4a9efbd32bd","raw":{"aspect":"P","body_system":"eye","disease_id":"OMIM:616277","disease_name":"Mitochondrial short-chain enoyl-coa hydratase 1 deficiency","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0000639","is_excluded":false,"label":"Nystagmus","onset_id":null,"reference":"OMIM:616277","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"6c2db7fd34f68f3dcf2e7bce27f748b1a23ab2d71bd404971cebe421b204b183","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:616277","disease_name":"Mitochondrial short-chain enoyl-coa hydratase 1 deficiency","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0001257","is_excluded":false,"label":"Spasticity","onset_id":null,"reference":"OMIM:616277","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"count","key":"6e7a0b5a032b4bc69d03f870321c335f841ac3be980c33e1390670b7bc3343ec","raw":{"aspect":"P","body_system":"respiratory","disease_id":"OMIM:616277","disease_name":"Mitochondrial short-chain enoyl-coa hydratase 1 deficiency","evidence":"PCS","frequency_raw":"2/2","hpo_id":"HP:0002104","is_excluded":false,"label":"Apnea","onset_id":null,"reference":"PMID:25125611","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"7559ca367a8f08d9da469276f197fc63dba6be8efc893cfabdde637c396f38e9","raw":{"aspect":"P","body_system":"digestive","disease_id":"OMIM:616277","disease_name":"Mitochondrial short-chain enoyl-coa hydratase 1 deficiency","evidence":"PCS","frequency_raw":"1/2","hpo_id":"HP:0011968","is_excluded":false,"label":"Feeding difficulties","onset_id":null,"reference":"PMID:25125611","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"92a28e19384ed910b9b9f06033dc64493774856a83a09ed39db01602da5c589b","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:616277","disease_name":"Mitochondrial short-chain enoyl-coa hydratase 1 deficiency","evidence":"PCS","frequency_raw":"2/2","hpo_id":"HP:0002490","is_excluded":false,"label":"Increased CSF lactate","onset_id":null,"reference":"PMID:25125611","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"96587f5b220c611368c34752316d29965f4fa6a8ac6a91ab2ff50907e9f4ffe3","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:616277","disease_name":"Mitochondrial short-chain enoyl-coa hydratase 1 deficiency","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0001332","is_excluded":false,"label":"Dystonia","onset_id":null,"reference":"OMIM:616277","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"count","key":"ae7b602ca6b883ec50c494c60fa434a2a6cedf9a6248ff058a067d2915d6fb9d","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:616277","disease_name":"Mitochondrial short-chain enoyl-coa hydratase 1 deficiency","evidence":"PCS","frequency_raw":"2/2","hpo_id":"HP:0012707","is_excluded":false,"label":"Elevated brain lactate level by MRS","onset_id":null,"reference":"PMID:25125611","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"c55edac742928ff47c4c5421a61556d9f05d73ec647f0014ab1528960eabb1d6","raw":{"aspect":"P","body_system":"respiratory","disease_id":"OMIM:616277","disease_name":"Mitochondrial short-chain enoyl-coa hydratase 1 deficiency","evidence":"PCS","frequency_raw":"1/2","hpo_id":"HP:0002878","is_excluded":false,"label":"Respiratory failure","onset_id":null,"reference":"PMID:25125611","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"d0180bd0a73017b7b1bea5f462e76a59781edf7c69600b6569bffbb4170438bb","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:616277","disease_name":"Mitochondrial short-chain enoyl-coa hydratase 1 deficiency","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0001252","is_excluded":false,"label":"Hypotonia","onset_id":null,"reference":"OMIM:616277","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"count","key":"d3d4bee3a10c39fa444152f9aa4c00303d00913f5c194c191bb005c3af96c7c1","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"OMIM:616277","disease_name":"Mitochondrial short-chain enoyl-coa hydratase 1 deficiency","evidence":"PCS","frequency_raw":"1/2","hpo_id":"HP:0001639","is_excluded":false,"label":"Hypertrophic cardiomyopathy","onset_id":null,"reference":"PMID:25125611","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"d5f75443c96058b7688cdfe8887616c5430a421f4c29cbc157292c940954f6bd","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"OMIM:616277","disease_name":"Mitochondrial short-chain enoyl-coa hydratase 1 deficiency","evidence":"PCS","frequency_raw":"1/2","hpo_id":"HP:0001629","is_excluded":false,"label":"Ventricular septal defect","onset_id":null,"reference":"PMID:25125611","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"da28cd39e3996fc7507165fdfafbba3707141d73dad2eb60152a88ea5372832a","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:616277","disease_name":"Mitochondrial short-chain enoyl-coa hydratase 1 deficiency","evidence":"PCS","frequency_raw":"1/2","hpo_id":"HP:0012444","is_excluded":false,"label":"Brain atrophy","onset_id":null,"reference":"PMID:25125611","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"df81931150baed6b864fa6ebc419c5856d7d45cc44528e4778e1c0951df58c14","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:616277","disease_name":"Mitochondrial short-chain enoyl-coa hydratase 1 deficiency","evidence":"PCS","frequency_raw":"2/2","hpo_id":"HP:0001290","is_excluded":false,"label":"Generalized hypotonia","onset_id":null,"reference":"PMID:25125611","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"fc5ec1eecf4e61bbb0467857ca6ef10e390728e2c4275effca66e2b0d0554c16","raw":{"aspect":"P","body_system":"digestive","disease_id":"OMIM:616277","disease_name":"Mitochondrial short-chain enoyl-coa hydratase 1 deficiency","evidence":"PCS","frequency_raw":"1/2","hpo_id":"HP:0002033","is_excluded":false,"label":"Poor suck","onset_id":null,"reference":"PMID:25125611","source_release":"2026-06-23"},"sourceGroups":["published"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/13019\" rel=\"noreferrer\">GARD</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>summary</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>automatic-identity-and-attribution</dd><dt>Upstream attribution</dt><dd>GARD:0013019</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>Mitochondrial short-chain enoyl-CoA hydratase 1 deficiency (ECHS1D) represents a clinical spectrum in which several phenotypes have been described: The most common phenotype presents in the neonatal period with severe encephalopathy and lactic acidosis and later manifests Leigh-like signs and symptoms. Those with presentation in the neonatal period typically have severe hypotonia, encephalopathy, or neonatal seizures within the first few days of life. Signs and symptoms typically progress quickly and the affected individual ultimately succumbs to central apnea or arrhythmia. A second group of affected individuals present in infancy with developmental regression resulting in severe developmental delay. A third group of affected individuals have normal development with isolated paroxysmal dystonia that may be exacerbated by illness or exertion. Across all three groups, T2 hyperintensity in the basal ganglia is very common, and may affect any part of the basal ganglia.</p><p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/13019\" rel=\"noreferrer\">GARD</a></p>","key":"overview","title":"Overview"}],"sharedSources":[],"slug":"mitochondrial-short-chain-enoyl-coa-hydratase-1-deficiency","sourceDocuments":[{"name":"GARD: Mitochondrial short-chain Enoyl-Coa hydratase 1 deficiency","reviewed":null,"source_release":"2026-10-21T17:00:16Z","url":"https://rarediseases.info.nih.gov/diseases/13019"}],"sourceNote":"","synonyms":["ECHS1D","mitochondrial short-chain Enoyl-Coa hydratase 1 deficiency","short-chain enoyl-CoA hydratase deficiency"],"takeawayHtml":"","title":"mitochondrial short-chain Enoyl-Coa hydratase 1 deficiency"},"schemaVersion":1}
